Optimal Versus Suboptimal Treatment for HIV-Infected Pregnant Women and HIV-Exposed Infants in Clinical Research Studies.
- Resource Type
- Editorial
- Authors
- Ammann, Arthur J.
- Source
- JAIDS: Journal of Acquired Immune Deficiency Syndromes. 8/15/2009, Vol. 51 Issue 5, p509-512. 4p.
- Subject
- *HIGHLY active antiretroviral therapy
*PREGNANCY complications
*MOTHER-infant relationship
*HIV infection transmission
*HIV-positive women
*HIV prevention
*CLINICAL trials
*HEALTH
- Language
- ISSN
- 1525-4135
The author reflects on the use of potent and subpotent treatment for HIV-positive pregnant women and HIV-exposed infants. He references several clinical research studies that demonstrate the use of treatments such as highly active antiretroviral therapy (HAART) for the prevention of mother-to-child transmission of HIV (PMTCT), and concerns on the considered optimal treatment in resource-limited countries. He discusses the implications of the use of subpotent treatment for HIV-infected children.